How do reagent-rental contracts affect laboratory purchasing decisions in the Blood Group Typing Market?

Reagent-rental agreements eliminate upfront capital expenditure by placing instruments at no charge in exchange for committed consumable volumes. They lower entry barriers for smaller facilities but create long-term vendor lock-in that can limit technology flexibility [9]. Read More

What role does the EU IVDR reclassification play in reshaping competitive dynamics?

Class D reclassification raises conformity-assessment costs to roughly USD 2–4 Million per product, forcing smaller manufacturers to consolidate or exit [13]. This accelerates market concentration toward global players with diversified regulatory portfolios. Read More

How does extended antigen genotyping change per-patient testing economics?

Molecular genotyping panels cost USD 50–120 per patient compared to USD 5–10 for basic serology, but reduce alloimmunization-related costs significantly [7]. The net clinical value proposition drives adoption in chronically transfused populations. Read More

What infrastructure gaps limit the Blood Group Typing Market growth in sub-Saharan Africa?

Unreliable cold chains, intermittent power supply, and a shortage of trained laboratory personnel constrain reagent utilization rates [1]. Tropicalized room-temperature platforms are needed to unlock this region's potential. Read More

How are cybersecurity concerns affecting blood-bank information systems?

Blood banks store sensitive donor health data subject to HIPAA and GDPR. Recent ransomware incidents targeting hospital networks have prompted investment in air-gapped LIS architectures and encrypted data transmission [15]. Read More

What distinguishes gel-card technology from solid-phase red-cell adherence methods?

Gel-card systems use dextran-acrylamide columns to trap agglutinated cells, while solid-phase methods immobilize antigens on microplate wells [12]. Both offer superior standardization over tube testing, but gel cards dominate due to broader antigen menus. Read More

How might liquid-biopsy platforms intersect with blood-typing workflows?

Liquid-biopsy instruments already extract and analyze cell-free DNA, a capability adaptable to blood-group genotyping from plasma [18]. Convergence could enable combined oncology and immunohematology testing on shared platforms by 2030. Read More

Blood Group Typing Market (2026 - 2035)

ID: MRFR/MED/4949-HCR

90 Pages

Rahul Gotadki

Last Updated: July 15, 2026

Blood Group Typing Market Research Report By Technology (Serological Testing, Molecular Testing, Microarray Technology, Next Generation Sequencing), By Product Type (Reagents, Instruments, Software, Consumables), By Application (Blood Donation, Transfusion, Organ Transplantation, Disease Diagnosis), By End User (Hospitals, Blood Banks, Diagnostic Laboratories, Research Institutions) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Industry Forecast to 2035.

Blood Group Typing Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)8.2%

2025 Market SizeUSD 2.41 Billion

2035 Market SizeUSD 5.31 Billion

Key Players

Bio-Rad Laboratories

Grifols S.A.

QuidelOrtho

Immucor

Quotient Limited

BAG Healthcare GmbH

Trends

Rising Global Surgical Volumes
Government Blood-Safety Mandates
Automation of Blood-Bank Workflows

Opportunities

Point-of-Care Blood Typing in Emergency and Military Settings
AI-Integrated Image Interpretation
Emerging-Market Infrastructure Buildout

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Rising Global Surgical Volumes | |
  2. 3.1.2 Government Blood-Safety Mandates | |
  3. 3.1.3 Automation of Blood-Bank Workflows | |
  4. 3.1.4 Molecular Genotyping Adoption | |
  5. 3.1.5 Hospital System Consolidation and Bundled Procurement | |
  6. 3.1.6 Aging Population and Chronic Disease Burden | |
  7. 3.1.7 Expanding Voluntary Blood-Donation Campaigns |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 High Capital Cost of Automated Platforms | |
  2. 3.2.2 Reagent Cold-Chain and Shelf-Life Limitations | |
  3. 3.2.3 Regulatory Fragmentation Across Jurisdictions | |
  4. 3.2.4 Reimbursement Compression in Mature Markets | |
  5. 3.2.5 Data Interoperability and LIS Integration Gaps |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Point-of-Care Blood Typing in Emergency and Military Settings | |
  2. 3.3.2 AI-Integrated Image Interpretation | |
  3. 3.3.3 Emerging-Market Infrastructure Buildout | |
  4. 3.3.4 Data Monetization Through Digital Donor Registries | |
  5. 3.3.5 Companion Diagnostics for Cell and Gene Therapy |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Blood Group Typing Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Product | |
  1. 5.1.1 Instruments | |
  2. 5.1.2 Consumables | |
  3. 5.1.3 Services |
2. 5.2 By Technique | |
  1. 5.2.1 Serology Assay-Based | |
  2. 5.2.2 PCR-Based & Microarray | |
  3. 5.2.3 Others (Including NGS) |
3. 5.3 By Test Type | |
  1. 5.3.1 ABO Blood Tests | |
  2. 5.3.2 Antibody Screening | |
  3. 5.3.3 Antigen Typing & Others |
4. 5.4 By End User | |
  1. 5.4.1 Hospitals | |
  2. 5.4.2 Diagnostic Laboratories & Others
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Bio-Rad Laboratories | |
  2. 7.3.2 Grifols S.A. | |
  3. 7.3.3 QuidelOrtho | |
  4. 7.3.4 Immucor (Werfen) | |
  5. 7.3.5 Quotient Limited | |
  6. 7.3.6 BAG Healthcare GmbH | |
  7. 7.3.7 Beckman Coulter (Danaher) | |
  8. 7.3.8 Agena Bioscience | |
  9. 7.3.9 Merck KGaA | |
  10. 7.3.10 Hemo Bioscience
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI-Driven Antibody Identification |
2. 8.2 Platform Consolidation and Bundled Economics |
3. 8.3 Precision Transfusion and Extended Genotyping |
4. 8.4 Sustainability and Reagent Innovation
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Blood Group Typing Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Blood Group Typing Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Global Blood Group Typing Market — Driver Impact Analysis |
TABLE 4 Global Blood Group Typing Market — Restraint Impact Analysis |
TABLE 5 Global Blood Group Typing Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 6 Global Blood Group Typing Market Size, by Technique, 2021–2035 (USD Billion) |
TABLE 7 Global Blood Group Typing Market Size, by Test Type, 2021–2035 (USD Billion) |
TABLE 8 Global Blood Group Typing Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 9 Global Blood Group Typing Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 10 North America Blood Group Typing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Europe Blood Group Typing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 Asia-Pacific Blood Group Typing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 South America Blood Group Typing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 Middle East & Africa Blood Group Typing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 15 Competitive Benchmarking Matrix — Global Blood Group Typing Market, 2025 |
TABLE 16 Company Profiles — Key Players, Global Blood Group Typing Market |
TABLE 17 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 18 Report Scope & Methodology Summary |
TABLE 19 Detailed Sources and Citations
13 LIST OF FIGURES |
FIGURE 1 Blood Group Typing Market Dynamics — Drivers, Restraints, and Opportunities |
FIGURE 2 Industry Value Chain Analysis — Blood Group Typing Market |
FIGURE 3 Porter's Five Forces Analysis — Blood Group Typing Market |
FIGURE 4 Global Blood Group Typing Market Size Trend & Forecast, 2021–2035 (USD Billion) |
FIGURE 5 Blood Group Typing Market Share, by Product, 2025 (%) |
FIGURE 6 Blood Group Typing Market Share, by Technique, 2025 (%) |
FIGURE 7 Blood Group Typing Market Share, by Test Type, 2025 (%) |
FIGURE 8 Blood Group Typing Market Share, by End User, 2025 (%) |
FIGURE 9 Blood Group Typing Market Share, by Region, 2025 (%) |
FIGURE 10 North America Blood Group Typing Market — Country-Level Revenue Split, 2025 |
FIGURE 11 Europe Blood Group Typing Market — Country-Level Revenue Split, 2025 |
FIGURE 12 Asia-Pacific Blood Group Typing Market — Country-Level Revenue Split, 2025 |
FIGURE 13 South America Blood Group Typing Market — Country-Level Revenue Split, 2025 |
FIGURE 14 Middle East & Africa Blood Group Typing Market — Country-Level Revenue Split, 2025 |
FIGURE 15 Competitive Landscape — Market Share of Top 5 Players, 2025

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product	Instruments, Consumables, Services	Consumables	Services
By Technique	Serology Assay-Based, PCR-Based & Microarray, Others (incl. NGS)	Serology Assay-Based	Others (incl. NGS)
By Test Type	ABO Blood Tests, Antibody Screening, Antigen Typing & Others	ABO Blood Tests	Antigen Typing & Others
By End User	Hospitals, Diagnostic Laboratories & Others	Hospitals	Diagnostic Laboratories & Others
By Region	North America, Europe, Asia-Pacific, South America, Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Product

Sub-Segment	Key Trend
Instruments	Migration from semi-automated to fully automated walk-away analyzers with AI-assisted image reading
Consumables	Growing demand for multiplexed gel cards and molecular genotyping kits with extended antigen panels
Services	Shift toward managed-service and reagent-rental contracts that bundle support, training, and reference testing.

The product segmentation reflects a classic installed-base business model where instrument placements drive long-term consumable revenues. Services are emerging as a strategic differentiator as laboratories seek to outsource increasingly complex testing workflows.

By Technique

Sub-Segment	Key Trend
Serology Assay-Based	Transition from manual tube to automated column-agglutination and solid-phase platforms
PCR-Based & Microarray	Expanding use for extended genotyping in chronically transfused and prenatal patient populations
Others (incl. NGS)	Adoption for research, rare blood-group resolution, and large-scale donor registry genotyping

Technique segmentation captures the ongoing transition from phenotypic to genotypic blood classification. Serology will remain dominant for routine testing, but molecular methods are becoming indispensable for clinical scenarios requiring antigen-level precision.

By Test Type

Sub-Segment	Key Trend
ABO Blood Tests	Universal procedural requirement with high-volume, low-cost-per-test economics
Antibody Screening	Regulatory mandates are expanding to all transfusion recipients in additional jurisdictions.
Antigen Typing & Others	Extended matching protocols for sickle-cell, thalassemia, and transplant patients

Test-type segmentation highlights the expanding clinical scope of blood typing beyond basic ABO/Rh classification. Antigen typing represents the primary growth frontier as evidence links extended matching to reduced adverse transfusion outcomes.

By End User

Sub-Segment	Key Trend
Hospitals	On-site blood-bank laboratories remain the primary testing venue, driven by regulatory requirements.
Diagnostic Laboratories & Others	Centralized reference labs and blood-center testing facilities are gaining share through economies of scale

End-user segmentation reflects the tension between decentralized hospital-based testing and the economic efficiency of centralized laboratory models. Both channels are growing, but stand-alone laboratories are expanding faster as regional health systems rationalize testing infrastructure.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”